A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9

NCT02946606 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult Growth Hormone Deficiency

Interventions

DRUG: GX-H9
DRUG: Genotropin

Sponsor

Genexine, Inc.